青年起病2型糖尿病的表型聚类未优于简单临床指标
研究基于TODAY(n=525)和SEARCH(n=333)两个队列中自身抗体阴性、临床诊断的青年起病2型糖尿病患者,采用数据驱动聚类方法识别出三种表型聚类,发现聚类对治疗反应和并发症风险有差异,但聚类成员在预测结局方面未比简单临床指标提供额外临床效用。
要点
- 青年起病2型糖尿病可聚类为胰岛素缺乏型、胰岛素抵抗型和中间型。
- 胰岛素缺乏型聚类治疗失败率最高,且2型糖尿病并发症发生率高。
- 聚类成员预测结局未优于简单临床指标。
核心结论
- 青年起病2型糖尿病可聚类为可重复的表型,对治疗反应和并发症风险有差异,但聚类未比简单临床指标提供额外临床效用。
研究设计与样本
- 数据驱动聚类分析,纳入TODAY研究(n=525)和SEARCH研究(n=333)中自身抗体阴性、临床诊断的20岁前起病2型糖尿病患者。
主要发现
- 识别出三种聚类:青年起病胰岛素缺乏型糖尿病(YIDD-T2)、青年起病胰岛素抵抗型糖尿病和中间型青年起病糖尿病。
- YIDD-T2聚类在TODAY研究中治疗失败率最高,无论治疗分组如何,且2型糖尿病并发症发生率高。
- 使用常规临床实践变量生成三种新聚类,治疗失败率不同。
- 简单临床指标在预测治疗反应和并发症方面与两种聚类方法相当或更优。
临床怎么用
- 简单临床指标可用于预测青年起病2型糖尿病的治疗反应和并发症风险,聚类分型未显示额外临床效用。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Clinical heterogeneity in youth-onset type 2 diabetes is less understood than that of adult-onset type 2 diabetes. We performed phenotypic clustering of youth-onset type 2 diabetes to determine whether clusters provided clinical utility. RESEARCH DESIGN AND METHODS: We performed data-driven clustering in a diverse subset of autoantibody-negative, clinician-diagnosed type 2 diabetes before age 20 years in the Treatment Options for Type 2 Diabetes in Adolescents and Youth (TODAY) (n = 525) and the SEARCH for Diabetes in Youth (SEARCH) (n = 333) studies. Participants were clustered using 1) similar variables as previously described in adults and 2) novel routinely available clinical variables. We assessed the effectiveness of the clusters, as well as that of simple clinical measures, to predict treatment response in the TODAY clinical trial. RESULTS: There were three youth-onset type 2 diabetes clusters: 1) youth-onset insulin-deficient diabetes (YIDD-T2), 2) youth-onset insulin-resistant diabetes, and 3) intermediate youth-onset diabetes. These clusters had differential responses to therapies and risk of treatment failure in the TODAY study, with those in the YIDD-T2 cluster experiencing the highest rate of treatment failure, regardless of treatment arm. YIDD-T2 also had high rates of type 2 diabetes complications. We then generated three novel clusters, with different rates of treatment failure, using variables available in routine clinical practice. Compared with both clustering methods, simple clinical measures performed comparably or better at predicting treatment response and complications. CONCLUSIONS: Youth-onset type 2 diabetes can be characterized into reproducible clusters that demonstrate differential response to treatments and risk of complications. Nevertheless, cluster membership did not add clinical utility beyond simple clinical measures for predicting outcomes.
引用
- Kreienkamp RJ, Smith K, Wangden TY, et al. Novel Phenotypic Clusters of Youth-Onset Type 2 Diabetes Offer No Added Prognostic Value to Simple Clinical Measures. Diabetes Care. 2026. PMID: 41237324. doi:10.2337/dc25-1765
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。